Latest Rofecoxib Stories
Head to Head: Is the conflict of interest unacceptable when drug companies conduct trials on their own drugs?
Clinical trial data indicated an association between the anti-inflammatory medication rofecoxib and cardiovascular risk as early as December 2000, before the product was taken off the market in September 2004.
Provides lessons for post-market pharmaceutical safety.
ENGLEWOOD, Colo., Nov. 13 /PRNewswire/ -- On November 10, 2009, Judge David R. Herndon, the federal judge presiding over the Yasmin and Yaz (Drospirenone) Marketing Sales Practices and Product Liability Multidistrict Litigation MDL #2100 in the Southern District of Illinois, appointed Michael S.
NEW YORK, Oct. 7 /PRNewswire/ -- Reflecting another strong year of major trial wins, multi-million dollar settlements and key leadership appointments in a variety of complex litigation matters, the firm of Seeger Weiss LLP has once again been named to the National Law Journal's Plaintiffs Hot List.
A study published this week in the open access journal PLoS Medicine shows that for elderly people at risk of cardiovascular disease, the presence of inflammatory markers in the blood can identify that an individual is at a higher risk of a fatal rather than a non-fatal heart attack or stroke.
Federal regulators said on Friday new labels on popular asthma drugs like Merck's Singulair must highlight language about suicidal behavior, depression and anxiety seen in a small number of patients.
An analysis of previous studies indicates that among patients with peripheral artery disease, aspirin use is associated with a statistically nonsignificant decrease in the risk of a group of combined cardiovascular events
A chemical component of licorice may offer a new way to prevent colorectal cancer without the adverse side effects of other therapies, U.S. researchers said.
MORRISTOWN, N.J., March 18 /PRNewswire/ -- Concerns still persist within the general clinical community regarding the cardiovascular and gastrointestinal risk that is associated with the use of analgesics such as the nonsteroidal anti-inflammatory drugs (NSAIDs).
- The governor of a province or people.